Mesco Pharmaceuticals (Delisted) financials and balance sheet

BSE: 500274Pharmaceuticals & Biotechnology

Last traded ₹4.54 on 10 Jan 2022

Delisted on 12 Nov 2023.

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Mesco Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹0.00 Cr, year to Mar 2019A loss in 5 of the 5 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses0.0
  4. Operating profit0.0
  5. Depreciation0.0
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs0.0
  9. Profit before tax0.0
  10. Tax0.0
  11. Net profit0.0

What the company owns

  • Plant, investments and other assets₹0 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹11 Cr
  • Owed to suppliers₹0 Cr

Profit and loss

Standalone, ₹ crore, years to March.Mesco Pharmaceuticals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 5 JunMar 2020Filed 5 AugMar 2021Filed 8 Jul
Revenue from operations––0.000.000.00
––0.410.100.00
Materials and goods bought––0.000.000.00
Employee costs––0.000.000.00
Other expenses––0.410.100.00
Operating profit before depreciation––−0.41−0.100.00
Depreciation and amortisation––0.000.000.00
Operating profit after depreciation––−0.41−0.100.00
Other income––0.000.000.00
Finance costs–0.000.000.000.00
One-off items––0.000.000.00
Profit before tax−0.26−0.09−0.41−0.100.00
Tax0.00–0.000.000.00
Net profit−0.26−0.09−0.41−0.100.00
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its revenue, finance costs or depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2018: the statement does not state its revenue or depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2021, after the latest full year: the balance sheet at its end.

₹ croreMar 2019Filed 5 JunMar 2020Filed 5 AugMar 2021Filed 8 JulSep 2021Half yearFiled 16 Nov
−10,91,490−11−11−11
Share capital19,73,810202020
Reserves−30,65,300−31−31−31
Borrowings11,13,927111111
2,360000
11,13,927111111
Total assets24,797000
20,838000
Assets turning to cash within a year3,959000
Net debt11,09,968111111
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2021, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 8 JulSep 2021Half yearFiled 16 Nov
0.000.00
0.000.00
Of which working capital–0.00
Capital spending0.000.00
Free cash flow0.000.00
Cash from investing−0.030.00
Cash from financing0.000.00
Dividends paid0.000.00
Shares bought back0.000.00
Shares issued0.000.00
Net change in cash−0.040.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 5 JunMar 2020Filed 5 AugMar 2021Filed 8 Jul
Earnings per share−₹0.13–−₹0.20–₹0.00
Diluted earnings per share−₹0.13–−₹0.20–₹0.00
Earnings per share is left blank for the years to Mar 2018 and Mar 2020: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown.

Ratios

Standalone, years to March.

RatioMar 2019Filed 5 JunMar 2020Filed 5 AugMar 2021Filed 8 Jul
Return on capital employed0.0%−48.0%−2.4%
Asset turnover0.000.000.00
Assets per rupee of net worth−0.02−0.02−0.02
Sales per rupee of plant0.000.000.00
Plant being built, % of plant in use–0.0%0.0%
Debt to equity is left blank for the years to Mar 2019, Mar 2020 and Mar 2021: net worth is below zero, so there is no shareholders' money to set the borrowings against. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Return on assets, latest year
−2.0%
Measure3 years
Return on capital employed, average−16.8%
Asset turnover, average0.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2021.

₹ croreLatest year
Cash from operations0.00
Cash from investing−0.03
Cash from financing0.00
Capital spending0.00
Dividends paid0.00
Shares bought back0.00
Shares issued for cash0.00
Borrowings raised0.00
Borrowings repaid0.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2021
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets17.14
A threshold marked as ours has no published figure; it is the line we read the check against.